Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||
| Cash from operating activities | -28.90%61.37M | -39.74%86.32M | 88.38%143.24M | 169.67%76.04M | -109.14M |
| Net profit before non-cash adjustment | -42.34%86.99M | 31.11%150.87M | 71.94%115.07M | 180.37%66.93M | ---83.27M |
| Total adjustment of non-cash items | 698.82%21.75M | -106.72%-3.63M | 271.44%54.06M | -24.20%14.55M | --19.2M |
| -Depreciation and amortization | 48.07%1.65M | 16.18%1.11M | -78.00%958K | 223.72%4.35M | --1.35M |
| -Disposal profit | ---- | ---- | ---- | --413K | --0 |
| -Deferred income tax | ---620K | ---- | ---- | ---- | ---- |
| -Other non-cash items | 536.69%20.72M | -108.94%-4.75M | 442.59%53.1M | -45.19%9.79M | --17.86M |
| Changes in working capital | 22.25%-47.36M | -135.30%-60.92M | -375.50%-25.89M | 87.92%-5.45M | ---45.07M |
| -Change in receivables | 32.26%-79.53M | -104.18%-117.41M | -36.44%-57.5M | 46.09%-42.14M | ---78.17M |
| -Change in inventory | 48.20%1.52M | 123.31%1.03M | 129.27%459K | -15.72%-1.57M | ---1.36M |
| -Change in payables | -48.53%33.24M | 76.61%64.6M | 32.67%36.57M | -15.14%27.57M | --32.49M |
| -Provision for loans, leases and other losses | 71.53%-2.6M | -68.41%-9.13M | -150.69%-5.42M | 442.49%10.7M | --1.97M |
| Dividends paid (cash flow from operating activities) | |||||
| Dividends received (cash flow from operating activities) | |||||
| Interest paid (cash flow from operating activities) | -51.55%-4.74M | 6.23%-3.13M | 37.88%-3.34M | -17.73%-5.37M | -4.56M |
| Interest received (cash flow from operating activities) | 7,700.00%390K | 25.00%5K | 33.33%4K | -25.00%3K | 4K |
| Tax refund paid | 34.56%-38.42M | -529.49%-58.72M | -931.37%-9.33M | 106.67%1.12M | -16.83M |
| Other operating cash inflow (outflow) | -88.63%300K | 68.63%2.64M | -64.77%1.57M | 122.10%4.44M | 2M |
| Operating cash flow | -30.30%18.9M | -79.48%27.12M | 73.35%132.14M | 159.31%76.23M | ---128.52M |
| Investing cash flow | |||||
| Net PPE purchase and sale | -219.47%-6.01M | -91.84%-1.88M | 5.22%-980K | -598.65%-1.03M | ---148K |
| Net investment product transactions | ---- | ---10K | --0 | ---- | ---- |
| Net changes in other investments | -684.37%-33.46M | 184.22%5.73M | -68.48%-6.8M | -353.61%-4.04M | --1.59M |
| Investing cash flow | -1,128.97%-39.46M | 149.31%3.84M | -53.44%-7.78M | -451.28%-5.07M | --1.44M |
| Financing cash flow | |||||
| Net issuance payments of debt | 306.85%99.16M | 19.93%-47.94M | -182.09%-59.87M | 164.47%72.93M | ---113.12M |
| Net common stock issuance | -149.14%-7.08M | -94.52%14.4M | 925.77%262.6M | --25.6M | --0 |
| Net other fund-raising expenses | ---1K | ---- | ---1K | ---- | ---- |
| Financing cash flow | 374.56%92.08M | -116.54%-33.54M | 105.76%202.73M | 187.10%98.53M | ---113.12M |
| Net cash flow | |||||
| Beginning cash position | -0.37%693.53M | 88.64%696.11M | 85.13%369.02M | -54.65%199.33M | --439.53M |
| Current changes in cash | 2,865.47%71.52M | -100.79%-2.59M | 92.76%327.1M | 170.65%169.69M | ---240.2M |
| Cash adjustments other than cash changes | ---- | 100.00%2K | --1K | ---- | ---- |
| End cash Position | 10.31%765.04M | -0.37%693.53M | 88.64%696.11M | 85.13%369.02M | --199.33M |
| Free cash flow | -48.91%12.89M | -80.76%25.24M | 74.43%131.16M | 158.44%75.2M | ---128.67M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |